Lantheus Holdings Inc
Lantheus Holdings Inc (LNTH) Straddle
LNTH straddle scan found 11 qualifying long straddle setups on the previous trading day. Probability of profit reaches up to 80.8%.
Read more
Trading a LNTH straddle lets you take a pure volatility position on Lantheus Holdings Inc without committing to a direction. Lantheus Holdings Inc's straddle involves buying (or selling) a call and a put at the same strike and expiration, profiting when the stock moves more (or less) than the combined premium implies. Use our scanner to evaluate LNTH straddle pricing in real time and find the moments when expected moves are mispriced.
A long straddle on LNTH profits from large moves in either direction and is a classic play into binary events like earnings, product announcements, or macro releases. A short straddle profits when Lantheus Holdings Inc stays range-bound and implied volatility contracts. The breakeven points are simple: strike plus total premium on the upside, strike minus total premium on the downside. Comparing the LNTH straddle price to historical realized moves helps you judge whether the market is overpaying or underpaying for volatility.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors.
The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.
Earnings, product cycles, macro prints — any time volatility itself is the trade, the LNTH straddle is the cleanest expression of that view. Our scanner prices every LNTH straddle against historical realized moves, flags expirations where the market is overpaying or underpaying for vol, and ranks setups by breakeven width and IV rank. Whether you're long a LNTH straddle into a catalyst or short a LNTH straddle to harvest decay, the options straddle setups that matter are all in one place.
| Sep 17, 2027 | 105.00 | $5.20 | 365 | 10% | 80.8% | $110.20 | $99.80 | 0 |
| Jun 17, 2027 | 105.00 | $4.90 | 273 | 10% | 79.2% | $109.90 | $100.10 | 0 |
| Dec 17, 2027 | 100.00 | $6.15 | 456 | 10% | 78.8% | $106.15 | $93.85 | 21 |
| Apr 16, 2027 | 105.00 | $4.70 | 211 | 10% | 77.5% | $109.70 | $100.30 | 0 |
| Sep 17, 2027 | 100.00 | $5.93 | 365 | 10% | 77.2% | $105.93 | $94.08 | 0 |
| Jun 17, 2027 | 100.00 | $5.70 | 273 | 10% | 74.7% | $105.70 | $94.30 | 0 |
| Apr 16, 2027 | 100.00 | $5.30 | 211 | 10% | 73.3% | $105.30 | $94.70 | 8 |
| Jan 15, 2027 | 100.00 | $4.30 | 120 | 10% | 71.4% | $104.30 | $95.70 | 89 |
| Jan 15, 2027 | 105.00 | $4.73 | 120 | 10% | 71.1% | $109.73 | $100.28 | 2 |
| Dec 18, 2026 | 105.00 | $4.43 | 92 | 10% | 69.7% | $109.43 | $100.58 | 6 |
As of September 17, 2026
Find the right straddle before volatility moves
Track LNTH straddle pricing across expirations, filter by IV rank and breakeven points, and build a setup that fits your view before the move happens.
Start your 14-day free trial→